These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9301993)

  • 1. Carrier-mediated system for pefloxacin uptake in human monocytes.
    Mémin E; Panteix G; Revol A
    J Antimicrob Chemother; 1997 Aug; 40(2):263-8. PubMed ID: 9301993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the uptake of pefloxacin in human blood monocytes a simple diffusion process?
    Memin E; Panteix G; Revol A
    J Antimicrob Chemother; 1996 Nov; 38(5):787-98. PubMed ID: 8961048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus.
    Furet YX; Deshusses J; Pechère JC
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2506-11. PubMed ID: 1489194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway?
    Griffiths NM; Hirst BH; Simmons NL
    J Pharmacol Exp Ther; 1994 May; 269(2):496-502. PubMed ID: 8182517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Excretion of fluoroquinolones into saliva].
    Kelentey BA; Kelentey BJ; Fekete I; Kozma J
    Fogorv Sz; 1995 Sep; 88(9):293-7. PubMed ID: 8522025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of 4-fluoroquinolones permeation into saliva.
    Kozjek F; Suturkova LJ; Antolic G; Grabnar I; Mrhar A
    Biopharm Drug Dispos; 1999 May; 20(4):183-91. PubMed ID: 10440793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of fluoroquinolones in hepatic failure.
    Montay G; Gaillot J
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():61-7. PubMed ID: 2258353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residues of fluoroquinolone drugs in the cloacal gland and other tissues of Japanese quail.
    Mohan J; Sastry KV; Tyagi JS; Rao GS; Singh RV
    Br Poult Sci; 2006 Feb; 47(1):83-7. PubMed ID: 16546801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal elimination of ofloxacin enantiomers in the rat: evidence of a carrier-mediated process.
    Rabbaa L; Dautrey S; Colas-Linhart N; Carbon C; Farinotti R
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2126-30. PubMed ID: 8878593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of fluoroquinolones].
    Iakovlev VP
    Antibiot Khimioter; 1993 Jun; 38(6):66-78. PubMed ID: 8166571
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages.
    Carlier MB; Scorneaux B; Zenebergh A; Desnottes JF; Tulkens PM
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():27-39. PubMed ID: 2258352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of quinolones in renal insufficiency.
    Fillastre JP; Leroy A; Moulin B; Dhib M; Borsa-Lebas F; Humbert G
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():51-60. PubMed ID: 2124213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fluoroquinolones in clinical practice. Pefloxacin (abaktal, peflacine)].
    Fomina IP; Iudin SM; Kashina LB
    Antibiot Khimioter; 1995; 40(11-12):70-7. PubMed ID: 8830644
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereoselectivity of ofloxacin intestinal transport in the rat.
    Rabbaa L; Dautrey S; Colas-Linhart N; Carbon C; Farinotti R
    Drugs; 1995; 49 Suppl 2():333-4. PubMed ID: 8549352
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of pefloxacin in human prostatic tissue.
    Salpigides G; Pangalis A; Kouvelas D; Paradelis AG
    J Chemother; 1995 Nov; 7 Suppl 4():105-6. PubMed ID: 8904124
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterisation of DNA gyrase and measurement of drug accumulation in clinical isolates of Acinetobacter baumannii resistant to fluoroquinolones.
    Moreau NJ; Houot S; Joly-Guillou ML; Bergogne-Bérézin E
    J Antimicrob Chemother; 1996 Dec; 38(6):1079-83. PubMed ID: 9023657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity and uptake of pefloxacin, ciprofloxacin, and ofloxacin in primary cultures of rat hepatocytes.
    Nordmann P; Pechinot A; Kazmierczak A
    J Antimicrob Chemother; 1989 Sep; 24(3):355-63. PubMed ID: 2808191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report: pharmacokinetic and drug interaction studies of pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan.
    Gauhar S; Ali SA; Naqvi SB; Shoaib MH
    Pak J Pharm Sci; 2014 Mar; 27(2):389-95. PubMed ID: 24577931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of anxiogenic effects of fluoroquinolones in rats.
    Prabhu S; Rewari S
    Indian J Physiol Pharmacol; 1998 Jan; 42(1):135-8. PubMed ID: 9513807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum pharmacokinetics and in vitro antibacterial activity of pefloxacin, ofloxacin and ciprofloxacin].
    Nordmann P; Jarlier V
    Presse Med; 1990 Sep 1-8; 19(28):1321-5. PubMed ID: 2145562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.